本文選題：VEGF + nNOS��； 參考：《昆明醫(yī)學(xué)院》2011年碩士論文

【摘要】：目的：研究血管內(nèi)皮生長因子(vascular endothelial growth factor, VEGF)、神經(jīng)元型一氧化氮合酶(neuronal nitric oxide synthase, nNOS)在早期糖尿病大鼠視網(wǎng)膜中的定位及表達(dá)變化,探討二者在糖尿病視網(wǎng)膜病變(diabetic retinopathy, DR)發(fā)生發(fā)展中的作用,為DR的早期防治提供新的理論依據(jù)。 方法：選取健康雄性SD大鼠46只,隨機(jī)分成實(shí)驗(yàn)組和正常對(duì)照組。實(shí)驗(yàn)組用鏈脲佐菌素(streptozocin, STZ)大劑量(65mg/kg)一次性腹腔注射誘導(dǎo)1型糖尿病模型,對(duì)照組注射同樣體積的檸檬酸緩沖液。造成糖尿病模型后按糖尿病病程分為三個(gè)實(shí)驗(yàn)組：3周組,6周組,9周組,每組10只。麻醉大鼠,固定眼球,石蠟包埋、切片,進(jìn)行蘇木素/伊紅(Hematoxylin-Eosin, HE)染色,光鏡下觀察視網(wǎng)膜組織結(jié)構(gòu)變化。免疫組織化學(xué)SP法,計(jì)算機(jī)圖像分析技術(shù)及蛋白質(zhì)免疫印跡技術(shù)檢測(cè)視網(wǎng)膜中VEGF、nNOS蛋白表達(dá)水平及其分布。 結(jié)果：HE染色顯示,視網(wǎng)膜在糖尿病3周時(shí)變化不明顯。隨著病程的延長,病變不斷加重,出現(xiàn)視網(wǎng)膜微血管玻璃樣變、管壁增厚及管腔狹窄等變化。免疫組織化學(xué)檢測(cè)顯示,正常組VEGF陽性細(xì)胞主要分布于視網(wǎng)膜的神經(jīng)節(jié)細(xì)胞層和內(nèi)網(wǎng)狀層。隨著糖尿病病程的進(jìn)展,VEGF表達(dá)的空間范圍擴(kuò)大到視網(wǎng)膜的內(nèi)核層、外網(wǎng)狀層及感光細(xì)胞層,VEGF蛋白表達(dá)水平逐漸升高,差異有統(tǒng)計(jì)學(xué)意義(P0.05)；nNOS主要分布于各組大鼠視網(wǎng)膜的神經(jīng)節(jié)細(xì)胞及內(nèi)網(wǎng)狀層的雙極細(xì)胞。nNOS免疫陽性反應(yīng)在正常對(duì)照組和糖尿病3周組之間差異無統(tǒng)計(jì)學(xué)意義(P0.05),糖尿病6周和9周組nNOS陽性細(xì)胞數(shù)顯著高于正常對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P0.05),糖尿病不同病程組之間相比,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。Western Blotting結(jié)果顯示,VEGF蛋白條帶在正常對(duì)照組表達(dá)較弱,與正常對(duì)照組相比,糖尿病3、6、9周組VEGF蛋白表達(dá)條帶相對(duì)光密度值逐漸增加,差異有統(tǒng)計(jì)學(xué)意義(P0.05)；正常對(duì)照組和糖尿病組均見nNOS蛋白表達(dá)條帶。糖尿病3周組nNOS蛋白表達(dá)條帶相對(duì)光密度值與對(duì)照組相比,差異無統(tǒng)計(jì)學(xué)意義(P0.05),糖尿病6周及9周組nNOS蛋白表達(dá)條帶相對(duì)光密度值顯著高于正常對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P0.05),糖尿病不同病程組之間相比,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。相關(guān)分析結(jié)果顯不,VEGF和nNOS蛋白表達(dá)水平存在著明顯的正相關(guān)關(guān)系(P0.01)。 結(jié)論：1 STZ誘導(dǎo)的1型糖尿病大鼠模型可以作為研究人類背景期DR的理想模型。 2在DR早期,隨著糖尿病病程的進(jìn)展,VEGF及nNOS蛋白表達(dá)逐漸升高,推測(cè)與視網(wǎng)膜三級(jí)神經(jīng)元傳導(dǎo)功能及神經(jīng)細(xì)胞功能紊亂有關(guān)。 3 VEGF和nNOS在DR早期的發(fā)生發(fā)展過程中存在著明顯的正相關(guān)關(guān)系。
[Abstract]:Objective: to study the localization and expression of vascular endothelial growth factor (VEGF) and neuronal nitric oxide synthase (nNOS) in the retina of early diabetic rats.To explore the role of both of them in the pathogenesis and development of diabetic retinopathy (DRD), and to provide a new theoretical basis for the early prevention and treatment of Dr.Methods: 46 healthy male SD rats were randomly divided into experimental group and normal control group.The model of type 1 diabetes was induced by intraperitoneal injection of streptozocin (STZ) at a large dose of 65 mg / kg in the experimental group and citric acid buffer of the same volume in the control group.According to the course of diabetes, the diabetic model was divided into 3 experimental groups: 3 weeks, 6 weeks and 9 weeks, 10 rats in each group.The rats were anesthetized, fixed eyeball, embedded in paraffin, sectioned and stained with hematoxylin / eosin (Hematoxylin-Eosin). The changes of retinal tissue structure were observed under light microscope.Immunohistochemical SP method, computer image analysis and Western blot technique were used to detect the expression and distribution of VEGF nNOS protein in retina.Results the changes of retina were not obvious at 3 weeks after diabetes.With the prolongation of the course of disease, the pathological changes were aggravated, such as retinal microvascular vitreous degeneration, wall thickening and lumen stenosis.Immunohistochemical examination showed that VEGF positive cells in normal group were mainly distributed in ganglion cell layer and inner reticular layer of retina.With the progression of diabetes mellitus, the expression of VEGF was extended to the inner layer of the retina, and the expression of VEGF protein increased gradually in the outer reticular layer and photoreceptor cell layer.The immunoreactivity of nNOS in the ganglion cells of the retina and the bipolar cells in the inner reticular layer was not significantly different between the normal control group and the diabetic 3-week group (P 0.05).The number of nNOS positive cells in the 6 and 9 week groups was significantly higher than that in the normal control group.There was a significant difference in the expression of VEGF-VEGF-protein in the normal control group and in the normal control group. The results of Western Blotting showed that the expression of VEGF-VEGF-protein was weaker in the normal control group than that in the normal control group.The relative optical density of VEGF protein expression band increased gradually in the control group and the diabetic group at 9 weeks, the difference was statistically significant (P 0.05), and the nNOS protein expression bands were found in the normal control group and the diabetic group.Compared with the control group, the relative optical density of nNOS protein expression band in the diabetes mellitus group was not significantly different from that in the control group (P 0.05). The relative optical density value of the nNOS protein expression band in the 6 and 9 weeks diabetic group was significantly higher than that in the normal control group.The difference was statistically significant (P 0.05), and there was significant difference between the different course groups of diabetes mellitus (P 0.05).The correlation analysis showed that there was a significant positive correlation between the expression level of nNOS and nNOS protein.Conclusion the rat model of type 1 diabetes induced by 1: 1 STZ can be used as an ideal model for the study of human background Dr.2 at the early stage of Dr, the expression of VEGF and nNOS protein increased gradually with the progression of diabetes mellitus, which was related to the conduction function of tertiary neurons in the retina and the dysfunction of nerve cell function.(3) there was a positive correlation between VEGF and nNOS in the early stage of Dr.
【學(xué)位授予單位】：昆明醫(yī)學(xué)院
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2011
【分類號(hào)】：R587.2;R774.1

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 劉蓓;馬戈甲;宋保強(qiáng);;靶向人VEGF165的SiRNA慢病毒的構(gòu)建和鑒定[J];中國美容醫(yī)學(xué);2011年07期

2 劉建民;孫鴻;黃良文;陳為;朱文瑞;;HIF-1和VEGF蛋白在膠質(zhì)瘤中的表達(dá)及意義[J];四川醫(yī)學(xué);2011年08期

3 黃新次;;血清VEGF和MMP-9含量動(dòng)態(tài)變化監(jiān)測(cè)在急性腦梗死患者中的臨床意義及研究[J];現(xiàn)代預(yù)防醫(yī)學(xué);2011年18期

4 葉國慶;鄭敏;;VEGF在乳腺癌、癌旁組織中表達(dá)及意義[J];中國高等醫(yī)學(xué)教育;2011年06期

5 鄭琦;鄭根主;許燕紅;;VEGF和P53在翼狀胬肉中的表達(dá)[J];河北醫(yī)藥;2011年14期

6 黃志勤;李洪亮;孫立波;程齊來;;齊墩果酸抗大鼠移植性肝癌作用的研究[J];安徽農(nóng)業(yè)科學(xué);2011年18期

7 古金成;王少柯;;加服自擬化濁益腎方治療早期糖尿病腎病的臨床觀察[J];廣西中醫(yī)藥;2011年03期

8 王曉露;解方為;陳曦;張霞;歐陽學(xué)農(nóng);;丹參酮IIA對(duì)大鼠移植性肝癌的抑制作用[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2011年11期

9 馬真;卓宋明;周路球;李娜;葉春幸;;血管內(nèi)皮功能異常與慢性阻塞性肺疾病[J];現(xiàn)代預(yù)防醫(yī)學(xué);2011年14期

10 張勇;齊振華;李樂賽;符曉華;彭小寧;張娜;于才紅;;乳香提取物對(duì)HL-60細(xì)胞株VEGF分泌及其Flt-1受體表達(dá)的影響[J];湖南師范大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2011年02期

相關(guān)會(huì)議論文 前10條

1 趙忠芳;呂仁榮;霍然;傅洪濱;徐廣琪;;普萘洛爾治療增生期血管瘤患兒血清中VEGF、MMP-9的變化[A];中華醫(yī)學(xué)會(huì)整形外科學(xué)分會(huì)第十一次全國會(huì)議、中國人民解放軍整形外科學(xué)專業(yè)委員會(huì)學(xué)術(shù)交流會(huì)、中國中西醫(yī)結(jié)合學(xué)會(huì)醫(yī)學(xué)美容專業(yè)委員會(huì)全國會(huì)議論文集[C];2011年

2 徐勇;黃仁魏;王東寧;林桂真;林東軍;何易;李旭東;林曲;;急性白血病血管內(nèi)皮生長因子(VEGF)和受體的表達(dá)及其臨床意義研究[A];中華醫(yī)學(xué)會(huì)第八次全國血液學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2004年

3 李飛;李樹清;;VEGF表達(dá)在局灶性腦缺血后亞低溫腦保護(hù)中的作用研究[A];中國病理生理學(xué)會(huì)第九屆全國代表大會(huì)及學(xué)術(shù)會(huì)議論文摘要[C];2010年

4 趙忠芳;呂仁榮;霍然;傅洪濱;徐廣琪;;普萘洛爾治療增生期血管瘤患兒血清中VEGF、MMP-9的變化[A];中華醫(yī)學(xué)會(huì)整形外科學(xué)分會(huì)第十一次全國會(huì)議、中國人民解放軍整形外科學(xué)專業(yè)委員會(huì)學(xué)術(shù)交流會(huì)、中國中西醫(yī)結(jié)合學(xué)會(huì)醫(yī)學(xué)美容專業(yè)委員會(huì)全國會(huì)議論文集[C];2011年

5 杜娟;王景美;錢曉萍;劉寶瑞;;COX-2和VEGF在胃癌中的表達(dá)和意義[A];中華醫(yī)學(xué)會(huì)腫瘤學(xué)分會(huì)第七屆全國中青年腫瘤學(xué)術(shù)會(huì)議——中華醫(yī)學(xué)會(huì)腫瘤學(xué)分會(huì)“中華腫瘤 明日之星”大型評(píng)選活動(dòng)暨中青年委員全國遴選論文匯編[C];2011年

6 田，

本文編號(hào)：1767549